<html><head><meta content="text/html; charset=UTF-8" http-equiv="content-type"><style type="text/css">ol{margin:0;padding:0}table td,table th{padding:0}.c2{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:156pt;border-top-color:#000000;border-bottom-style:solid}.c3{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:468pt;border-top-color:#000000;border-bottom-style:solid}.c0{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Times New Roman";font-style:normal}.c1{color:#000000;font-weight:700;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Times New Roman";font-style:normal}.c11{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c8{border-spacing:0;border-collapse:collapse;margin-right:auto}.c12{text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;text-decoration:underline}.c4{padding-top:0pt;padding-bottom:0pt;line-height:1.0;text-align:left}.c9{background-color:#ffffff;max-width:468pt;padding:72pt 72pt 72pt 72pt}.c10{color:inherit;text-decoration:inherit}.c6{height:0pt}.c7{height:11pt}.c5{height:21pt}.c13{font-style:italic}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Times New Roman";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Times New Roman"}p{margin:0;color:#000000;font-size:11pt;font-family:"Times New Roman"}h1{padding-top:20pt;color:#000000;font-size:20pt;padding-bottom:6pt;font-family:"Times New Roman";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h2{padding-top:18pt;color:#000000;font-size:16pt;padding-bottom:6pt;font-family:"Times New Roman";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h3{padding-top:16pt;color:#434343;font-size:14pt;padding-bottom:4pt;font-family:"Times New Roman";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Times New Roman";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Times New Roman";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Times New Roman";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}</style></head><body class="c9 doc-content"><p class="c11 c7"><span class="c0"></span></p><table class="c8"><tr class="c6"><td class="c2" colspan="1" rowspan="1"><p class="c4"><span class="c1">Where</span></p></td><td class="c2" colspan="1" rowspan="1"><p class="c4"><span class="c1">Who</span></p></td><td class="c2" colspan="1" rowspan="1"><p class="c4"><span class="c1">Concerns (Title)</span></p></td></tr><tr class="c6"><td class="c2" colspan="1" rowspan="1"><p class="c4"><span class="c0">Government</span></p></td><td class="c2" colspan="1" rowspan="1"><p class="c4"><span class="c0">Businesses</span></p></td><td class="c2" colspan="1" rowspan="1"><p class="c4"><span class="c0">Intellectual Property Barriers in DNA Hydrogel Innovation</span></p></td></tr><tr class="c5"><td class="c3" colspan="3" rowspan="1"><p class="c4"><span class="c1">Concerns</span></p></td></tr><tr class="c5"><td class="c3" colspan="3" rowspan="1"><p class="c4"><span class="c0">The rapid growth of hydrogel technologies has led to a surge in patent filings, creating legal challenges for businesses trying to commercialize DNA hydrogel-based protein delivery. As of &nbsp;2024, over 96,000 hydrogel-related patent documents had been filed worldwide, mainly in the United States and China (Fatimi et al., 2025). Many of these patents fall under the Patent Cooperation Treaty, reflecting an active push for international IP protection. DNA hydrogels often build on common material platforms like PEG, alginate, and chitosan, leading to overlapping claims or disputes over novelty. Businesses must navigate patent thickets &ndash; dense webs of overlapping patents on small variations of hydrogel formulations or methods. These increase legal costs and delay product launches. Small companies are especially affected due to high legal fees to ensure their product doesn&rsquo;t infringe on multiple existing patents. A single hydrogel-based product might involve components owned by different parties, triggering complex licensing or disputes. These legal uncertainties can discourage businesses from pursuing hydrogel-based innovation together, limiting collaboration, slowing therapeutic development, and leaving useful technologies unexploited. Without a careful IP strategy, commercialization could be delayed, prices could rise due to licensing costs, and access could be restricted.</span></p></td></tr><tr class="c5"><td class="c3" colspan="3" rowspan="1"><p class="c4"><span class="c1">Potential responses from&hellip;</span></p></td></tr><tr class="c5"><td class="c3" colspan="3" rowspan="1"><p class="c4"><span class="c0">Encourage the use of open-source licensing models or patent pools for foundational hydrogel technologies. Governments can support startups by subsidizing patent searches and filings, and by creating IP frameworks that balance innovation with public accessibility. International collaboration on IP standards could reduce redundancy and prevent anti-competitive practices.</span></p></td></tr><tr class="c5"><td class="c3" colspan="3" rowspan="1"><p class="c4"><span class="c1">References (APA)</span></p></td></tr><tr class="c5"><td class="c3" colspan="3" rowspan="1"><p class="c4"><span>Fatimi, A., Damiri, F., El Arrach, N., Hemdani, H., Musuc, A. M., &amp; Berrada, M. (2025). Hydrogel-Based Biomaterials: A Patent Landscape on Innovation Trends and Patterns. </span><span class="c13">Gels</span><span>, </span><span class="c13">11</span><span>(3), 216. </span><span class="c12"><a class="c10" href="https://www.google.com/url?q=https://doi.org/10.3390/gels11030216&amp;sa=D&amp;source=editors&amp;ust=1759988730602440&amp;usg=AOvVaw0lQfP2PxZWTOz7mqARpaMw">https://doi.org/10.3390/gels11030216</a></span><span class="c0">&nbsp;</span></p></td></tr></table><p class="c7 c11"><span class="c0"></span></p></body></html>